349 related articles for article (PubMed ID: 17257062)
21. Interleukin 21 signaling in B cells is required for efficient establishment of murine gammaherpesvirus latency.
Collins CM; Speck SH
PLoS Pathog; 2015 Apr; 11(4):e1004831. PubMed ID: 25875847
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency.
Clambey ET; Virgin HW; Speck SH
J Virol; 2000 Feb; 74(4):1973-84. PubMed ID: 10644370
[TBL] [Abstract][Full Text] [Related]
23. Absence of the uracil DNA glycosylase of murine gammaherpesvirus 68 impairs replication and delays the establishment of latency in vivo.
Minkah N; Macaluso M; Oldenburg DG; Paden CR; White DW; McBride KM; Krug LT
J Virol; 2015 Mar; 89(6):3366-79. PubMed ID: 25589640
[TBL] [Abstract][Full Text] [Related]
24. Conserved Gammaherpesvirus Protein Kinase Counters the Antiviral Effects of Myeloid Cell-Specific STAT1 Expression To Promote the Establishment of Splenic B Cell Latency.
Sylvester PA; Jondle CN; Stoltz KP; Lanham J; Dittel BN; Tarakanova VL
J Virol; 2021 Aug; 95(17):e0085921. PubMed ID: 34132573
[TBL] [Abstract][Full Text] [Related]
25. Role for MyD88 signaling in murine gammaherpesvirus 68 latency.
Gargano LM; Moser JM; Speck SH
J Virol; 2008 Apr; 82(8):3853-63. PubMed ID: 18256152
[TBL] [Abstract][Full Text] [Related]
26. Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.
Cieniewicz B; Dong Q; Li G; Forrest JC; Mounce BC; Tarakanova VL; van der Velden A; Krug LT
J Virol; 2015 Jul; 89(13):6562-74. PubMed ID: 25855746
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency.
Clambey ET; Virgin HW; Speck SH
J Virol; 2002 Jul; 76(13):6532-44. PubMed ID: 12050366
[TBL] [Abstract][Full Text] [Related]
28. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo.
Feldman ER; Kara M; Coleman CB; Grau KR; Oko LM; Krueger BJ; Renne R; van Dyk LF; Tibbetts SA
mBio; 2014 May; 5(3):e00981-14. PubMed ID: 24865551
[TBL] [Abstract][Full Text] [Related]
29. Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency
Gupta A; Owens SM; Oldenburg DG; White DW; Forrest JC
J Virol; 2022 Jun; 96(12):e0069022. PubMed ID: 35647668
[TBL] [Abstract][Full Text] [Related]
30. Interferon Regulatory Factor 3 Supports the Establishment of Chronic Gammaherpesvirus Infection in a Route- and Dose-Dependent Manner.
Johnson KE; Sylvester PA; Jondle CN; Aurubin CA; Tarakanova VL
J Virol; 2021 Apr; 95(9):. PubMed ID: 33597211
[TBL] [Abstract][Full Text] [Related]
31. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
32. Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.
Coleman CB; Nealy MS; Tibbetts SA
J Virol; 2010 Dec; 84(24):13045-52. PubMed ID: 20926565
[TBL] [Abstract][Full Text] [Related]
33. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.
Steed A; Buch T; Waisman A; Virgin HW
J Virol; 2007 Jun; 81(11):6134-40. PubMed ID: 17360749
[TBL] [Abstract][Full Text] [Related]
34. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency.
Gray KS; Allen RD; Farrell ML; Forrest JC; Speck SH
J Virol; 2009 Jan; 83(1):314-28. PubMed ID: 18971285
[TBL] [Abstract][Full Text] [Related]
35. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
36. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S; Kapadia SB; Speck SH; Virgin HW
J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
[TBL] [Abstract][Full Text] [Related]
37. Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host.
Cieniewicz B; Santana AL; Minkah N; Krug LT
Front Microbiol; 2016; 7():1202. PubMed ID: 27582728
[TBL] [Abstract][Full Text] [Related]
38. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo.
Willer DO; Speck SH
J Virol; 2003 Aug; 77(15):8310-21. PubMed ID: 12857900
[TBL] [Abstract][Full Text] [Related]
39. Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo.
Terrell S; Speck SH
PLoS Pathog; 2017 Aug; 13(8):e1006543. PubMed ID: 28767707
[TBL] [Abstract][Full Text] [Related]
40. Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade.
Forrest JC; Speck SH
J Virol; 2008 Aug; 82(15):7688-99. PubMed ID: 18495760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
